Skip to main content

Advertisement

Table 1 Characteristics of study subjects included for overall analysis

From: A novel workflow combining plaque imaging, plaque and plasma proteomics identifies biomarkers of human coronary atherosclerotic plaque disruption

  PCI Diagnostic angiography
Number (male) 58 (46) 23 (16)
Age [years (SD)] 66 (11) 68 (10)
Acute coronary syndrome [n (%)] 21 (36) 13 (57)
Smoking status [n (%)]
 Current smoker 16 (28) 3 (13)
 Ex-smoker >1 month 25 (43) 13 (57)
 Never smoked 17 (29) 7 (30)
Past history of IHD [n (%)]
 MI/ACS 22 (38) 7 (30)
 Stable angina 15 (26) 7 (30)
Hypertension [n (%)] 39 (67) 19 (83)
Hypercholesterolemia [n (%)] 45 (78) 13 (57)
Diabetes mellitus [n (%)] 14 (24) 4 (17)
Family history of IHD [n (%)] 29 (50) 12 (52)
Regular medication [n (%)]
 Aspirin 40 (69) 17 (74)
 Thienopyridine 23 (40) 11 (48)
 Statin 47 (81) 20 (87)
 β-blocker 33 (57) 14 (61)
 ACE inhibitor/ARB 38 (65) 19 (83)